Table of Contents

PerspectiveP:12-13

Parenteral formulations that use cyclodextrin as a delivery mechanism: a review and update
Marco Alloisio, Elena Azzolini

• Abstract
• PDF

CommentaryP:14-15

Treatment for triple-negative breast cancer with sacituzumab govitecan
Xinhuan Wan, Wei Zhu

• Abstract
• PDF

OpinionP:16-17

Pharmaceutical Production Re-envisioned: Increasing Agility for Global Patient Access
David Bosanquet, Christina Schut

• Abstract
• PDF

CommentaryP:18-19

Recent improvements in additive manufacturing methods used in the pharmaceutical industry
Allison Siu, Tim Rahmel

• Abstract
• PDF

OpinionP:20-21

A possible involvement for the gut microbiome in the pharmaco-toxicological dilemma of oleander
Afolake Arowolo, David Otohinoyi

• Abstract
• PDF